Clinical trial · no report yet · Phase 3
LUNG ART
Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
- NCT00410683 ↗
- Unknown
- Gustave Roussy, Cancer Campus, Grand Paris
- 55 commentary sources found
- Deep
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 29 | |
| YouTube | 13 | |
| Podcasts | 13 |
The trial
ClinicalTrials.gov- Official title
- Phase III Study Comparing Post-Operative Conformal Radiotherapy to No Post-Operative Radiotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer and Mediastinal N2 Involvement [Lung ART]
- Phase
- Phase 3
- Status
- Unknown
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- clinical observation; adjuvant therapy; 3-dimensional conformal radiation therapy
- Arms
- Radiotherapy · Experimental
- No radiotherapy · Active comparator
- Enrollment
- 500 (estimated)
- Primary outcomes
- Disease-free survival (DFS)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris with Intergroupe Francophone de Cancerologie Thoracique, The Christie NHS Foundation Trust, European Organisation for Research and Treatment of Cancer - EORTC
- Start
- Feb 2007
- Primary completion
- Jul 2018
- Results posted
- No
- Registry record
- NCT00410683 · updated Nov 20, 2020
Publications
linked from the registry- Predina J, Suliman R, Potter AL, Panda N, Diao K, Lanuti M, Muniappan A, Jeffrey Yang CF. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 May;165(5):1696-1709.e4. doi: 10.1016/j.jtcvs.2022.09.062. Epub 2022 Oct 18. PubMed 36610886
- Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. PubMed 34919827